Assessing the quality of care provided to patients prescribed high-risk drugs

Quality and Performance

Assessing the quality of care provided to patients prescribed high-risk drugs

Guiding the implementation of system changes and effective interventions

Facilitating Improvement

Guiding the implementation of system changes and effective interventions

Collaborating with subject matter experts and providers to create and disseminate necessary resources for quality improvement

Networking and Tool Development

Collaborating with subject matter Experts and providers to create and disseminate necessary resources for quality improvement

  Drug Safety

Improving medication use systems, reducing adverse drug events and developing innovative assessment and intervention resources

New York South Carolina Washington D.C.

Adverse drug events (ADEs) are a major cause of emergency department visits and hospital admissions among the elderly and contribute an additional $3.5 billion to U.S. health care costs.

Adverse events due to high risk drug classes such as anticoagulants, hypoglycemic agents, and opioids are often preventable, and improved management of these medications has been identified as a major public health priority in the Department of Health and Human Services’ National Action Plan for Adverse Drug Event Prevention.

A Community-Based Approach

IPRO has partnered with the Delmarva Foundation of Columbia MD and the Carolinas Center for Medical Excellence of Columbia SC to form the Atlantic Quality Innovation Network (AQIN), under contract with the Centers for Medicare & Medicaid Services (CMS). AQIN is working with providers, pharmacists, pharmacies and stakeholders in New York, the District of Columbia and South Carolina to reduce and monitor adverse drug event rates. To reduce and prevent the incidence of ADEs, we are convening community groups throughout the region that treat Medicare Fee-for-Service (FFS) beneficiaries taking three or more medications, including at least one of these high-risk medications: anticoagulants, diabetic agents and/or opioids.

Patients are at particularly high risk of medication errors and ADEs as they transition between care settings. For more information on effective care transitions and reduction of 30-day hospital re-admissions visit the AQIN Care Transitions page.

Goals

  • Reduce ADEs by 35 percent per 1,000 Medicare FFS beneficiaries screened by the year 2019.
  • Monitor ADE and re-admission rates among Medicare FFS beneficiaries prescribed anticoagulants, hypoglycemic agents or opioids by care setting, state, and region.

Additional Information

AQIN pharmacists have assembled topic-specific coalitions and related resources on targeted high-risk drug classes. For more information select a topic area below:

Initiatives

Care Coordination
Care Coordination DC
Resources
Care Coordination NY
Overview
Beneficiaries and Families
Healthcare Professionals
Other Website Resources
Tools and Resources
Past Success
Upcoming Events
Past Events
Blog
Contact Us
Care Coordination SC
Cardiovascular Health
Cardiovascular Health (DC)
Cardiovascular Health (NY)
Cardiovascular Health (SC)
Diabetes Self-Management
Diabetes Self-Management Education (DC)
Diabetes Self-Management Education (NY)
Diabetes Self-Management Education (SC)
Drug Safety
Anticoagulation Safety
Hypoglycemia Avoidance
Opioid Safety
Drug Safety (DC)
Drug Safety (NY)
Drug Safety (SC)
Hospital Safety
Hospital Safety (DC)
Hospital Safety (NY)
Hospital Safety (SC)
Immunization
Immunization (DC)
Immunization (SC)
SC Immunization Coalition Materials
Nursing Home Quality
Nursing Home Quality (DC)
Nursing Home Quality (NY)
Building Blocks for Quality
QAPI Self-Assessment
Casper Data
Eliminating Inappropriate Antipsychotic Medication Use
Clinical Quality Measures (QM)
Composite Measure Score
NHQCC Collaborative Kick-Off
NHQCC Collaborative Outcomes Congress
QI/QAPI
Using a System's Approach to Quality & Performance Improvement
Nursing Home Quality Care Collaborative (NHQCC) Learning
Engaging Staff in Individualized Care
QAPI Self-Assessment and Related Resources
QAPI In Action
Quality Improvement (QI) Resources
Quality Improvement Strategies
Steps to QAPI
Elements for Framing QAPI in Nursing Homes
Clinical Topics
Medication Use Tools & Resources
Pressure Ulcer Clinical Tools & Resources
Restraint Clinical Tools & Resources
Falls with Major Injuries
Health Care Acquired Conditions
Eliminating Long Term Care Re-Admissions Tools & Resources
Resources
Consumers
Nursing Home Quality (SC)
ACE e-Newsletter
Clinical Topics
Organizational Change
Presentations and Handouts
QI/QAPI
Upcoming Events
Community Based Sepsis
Educational Events/Webinars
Sepsis in the News
Tools and Resources
Technology-Enhanced Care
Meaningful Use of HIT (DC)
Meaningful Use of HIT (NY)
Meaningful Use of HIT (SC)
Transforming End of Life
Quality Payment Program
Quality Payment Program (NY)
Quality Payment Program (DC)
Quality Payment Program (SC)

Contact Us

New York
Anne Myrka, Director, Drug Safety
518-320-3591
anne.myrka@area-i.hcqis.org

District of Columbia
Jennifer Thomas, Project Manager
410-872-9698
Jennifer.Thomas@area-I.hcqis.org

South Carolina
Cheryl Anderson, Medication Safety Pharmacist
803-212-7560
Cheryl.Anderson@area-I.hcqis.org